Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
Transposons play essential role in early human development

Transposons play essential role in early human development

Study reveals life-changing impact of gene therapy for hemophilia B patients

Study reveals life-changing impact of gene therapy for hemophilia B patients

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Electric pulses boost gene therapy uptake in liver cells

Electric pulses boost gene therapy uptake in liver cells

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

Breakthrough gene therapy method utilizes bird retrotransposon for safe gene insertion

New collaborative proposes strategies to address extreme blood unavailability in rural settings

New collaborative proposes strategies to address extreme blood unavailability in rural settings

Early intervention crucial for faster back pain recovery

Early intervention crucial for faster back pain recovery

Hemoglobin-like protein plays an important role in the development of the heart, study finds

Hemoglobin-like protein plays an important role in the development of the heart, study finds

Liver trigger holds the key to boosting gene therapy success

Liver trigger holds the key to boosting gene therapy success

Silencing galectin 1 protein shrinks liver cancer tumors in mice

Silencing galectin 1 protein shrinks liver cancer tumors in mice

Gene therapy's double-edged sword: Breakthrough treatments face manufacturing and efficacy

Gene therapy's double-edged sword: Breakthrough treatments face manufacturing and efficacy

New CRISPR-based gene-editing tool could lead to better treatments for genetic disorders

New CRISPR-based gene-editing tool could lead to better treatments for genetic disorders

Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

New method of insulin delivery lowers the risk of hypoglycemia compared to current diabetes treatments

New method of insulin delivery lowers the risk of hypoglycemia compared to current diabetes treatments

This panel will decide whose medicine to make affordable. Its choice will be tricky.

This panel will decide whose medicine to make affordable. Its choice will be tricky.

UWaterloo expert helps develop database repository to manage treatment for hemophilia patients

UWaterloo expert helps develop database repository to manage treatment for hemophilia patients

Monthly prophylactic fitusiran injections effective in reducing bleeds in patients with hemophilia A or B

Monthly prophylactic fitusiran injections effective in reducing bleeds in patients with hemophilia A or B

New 'cutting edge' hemophilia treatment is a victory for patients, Tulane doctor says

New 'cutting edge' hemophilia treatment is a victory for patients, Tulane doctor says

Researchers discover a previously unknown mechanism that drives aging

Researchers discover a previously unknown mechanism that drives aging

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.